http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003166570-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-695 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-695 |
| filingDate | 2001-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec1f81ebc4de6fc128a82fdf795f6104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d276729998701a3d7fbfca4d89bbc22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a184e51951adcf86516e573c58878c91 |
| publicationDate | 2003-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003166570-A1 |
| titleOfInvention | Peptide and its use in the treatment of hyperpigmentation conditions |
| abstract | A peptide having the formula: n X—N(H)-A 1 -B 2 -C 3 -D 4 -Lys 5 -Lys 6 -Arg 7 -C(O)—Y n wherein n A, B, C and D are amino acid residues; n X is selected from the group consisting of H, a pharmaceutically acceptable amine blocking group and, together with Y, a covalent bond connecting the carbonyl group of Arg 7 to the amine group of A 1 ; and n Y is selected from the group consisting of OH, a pharmaceutically acceptable carboxyl blocking group and, together with X, a covalent bond connecting the carbonyl group of Arg 7 to the amine group of A 1 . Such peptides may be used topically to treat hyperpigmentation conditions such as melanism and melasma. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11534481-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018118115-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11338018-B2 |
| priorityDate | 2001-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.